No statistically significant differences were detected when different combinations of membranous-cytoplasmic EGFR/nuclear EGFR, membranous-cytoplasmic EGFR/SGLT1 and nuclear EGFR/SGLT1 expression levels were observed in CCRCC patients with NED compared to patients with progression of disease at 5 years follow-up (Table 6). Here, EGFR is linked to nonpapillary renal cell carcinoma.